$PRFX Cashflow Statement | Understand Stock

$PRFX

$0.76 +$0.02 (2.62%) Close

$PRFX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Consolidated Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Operating lease provided by controlling shareholder
Amortization of intangible assets
Exchange rate differences on cash, cash equivalents and restricted cash
Share-based compensation to employees and directors
Net change in operating lease asset and liability
Share-based compensation to service providers
Interest expense and amortization of discount on convertible notes
Warrant issuance costs
Interest income
Issuance costs
Revaluation of derivative warrant liability
Change in warrant liability valuation
Loss from inducement offer letter agreement

Changes in operating assets and liabilities, net of effects of businesses acquired:
Other current and non-current assets
Prepaid expenses and other current assets
Trade payables
Other accounts payable and accrued expenses
Employees, related liabilities and accrued expenses
Net cash used in operating activities

Cash flows from investing activities
Purchase of property and equipment
Cash acquired through business combination
Proceeds from short term deposits
Purchase of short-term deposit
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from issuance of convertible notes, net
Proceeds from issuance of shares, warrants and prefunded warrants
Proceeds from exercise of warrants
Proceeds from exercise and issuance of warrants
Proceeds from issuance of Ordinary shares At-the market offering
Proceeds From Inducement Offer Letter Agreement
Issuance costs
Proceeds from issuance of August and December 2019 convertible notes and warrants, net
Proceeds from issuance of ordinary shares under Initial Public Offering, net
Proceeds from Issuance of shares and pre-funded warrants
Net cash provided by financing activities

Effect of Exchange rate changes on cash, cash equivalents and restricted cash
Change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Acquisition of right-of-use assets by means of lease liabilities
Acquisition of technology in exchange for equity instruments
Supplemental cash flow information:
Cash and cash equivalents
Restricted cash

Comments